Yield10 Bioscience, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 3.68 million compared to USD 3.44 million a year ago. Basic loss per share from continuing operations was USD 15.36 compared to USD 16.8 a year ago. Diluted loss per share from continuing operations was USD 15.36 compared to USD 16.8 a year ago.
For the six months, revenue was USD 0.06 million compared to USD 0.252 million a year ago. Net loss was USD 7.46 million compared to USD 6.77 million a year ago. Basic loss per share from continuing operations was USD 33.36 compared to USD 33.12 a year ago. Diluted loss per share from continuing operations was USD 33.36 compared to USD 33.12 a year ago.